Quantitative Analysis of Bone Marrow Features Highlights Heterogeneity in Myelofibrosis Patients Treated with Zinpentraxin Alfa in a Phase II Clinical Study
Ryou H., Sirinukunwattana K., Wood R., Aberdeen A., Rittscher J., Weinberg O., Hasserjian R., Pozdnyakova O., Peale F., Higgins B., Lundberg P., Trunzer K., Harrison CN., Royston D.